Ferring Pharmaceuticals COVID-19 Business Continuity 

Ferring Pharmaceuticals is committed to working with local and international health authorities to help reduce the spread of COVID-19, while ensuring that we prioritise the health and well-being of our employees, critical workforces and patients.

Effective Monday March 16th, 2020, Ferring has suspended all face-to-face interactions with Healthcare Practitioners, suppliers and partners, and implemented remote working for its commercial and medical field force as well as its office-based support functions.

Implementing these measures allows our commercial and medical field force, along with all of our support functions to remain fully operational and committed to providing ongoing support to you, and to ensure that we can meet the needs of Australian patients. We are currently exploring ways to effectively engage remotely, to ensure we can provide effective and timely information and support during this time.

We will continue to monitor the situation and work closely with the Australian Health Authorities, and will keep you updated on any significant changes that could impact you, or our patients.

Best regards,

Hardus Van Vuuren

General Manager, ANZA